Express Pharma - Express Pharma

Only two monoclonal antibodies approved in both markets with no small molecules cleared

CDSCO approval enables planned March 2026 launch targeting Type 2 diabetes management

Following positive CHMP opinion, Lupin to commercialise RanluspecTM in EU through Sandoz partnership

Laboratory balance requirements across global pharmacopeias have been significantly revised to improve clarity, harmonization, and…

351(k) Biologics License Application for DRL_AB IV infusion targets rheumatoid arthritis, psoriatic arthritis and pJIA

Multi-year contract to commence supplies within 4–5 months, execution planned through Q1 of next financial year

Report highlights voltage-gated sodium channel inhibitors, pipeline trends and regulatory incentives in pain treatment

TIQ and Austrade engage with Indian biotech, clinical trials and MedTech stakeholders during Hyderabad and Bengaluru visit

Company commemorates centenary of founder and recalls his role in building India’s pharma manufacturing base

Vineet Unnikrishnan and Sonu Bhasi, Cyril Amarchand Mangaldas; examine the scope of directors’ liability and vicarious…